- Author: Venkat R Minnaganti, MD, FACP; Chief Editor: Michael Stuart Bronze, MD more...
Plague is an acute, contagious, febrile illness transmitted to humans by the bite of an infected rat flea. Human-to-human transmission is rare except during epidemics of pneumonic plague. The disease is caused by the plague bacillus, rod-shaped bacteria referred to as Yersinia pestis. Yersinia is named in honor of Alexander Yersin, who successfully isolated the bacteria in 1894 during the pandemic that began in China in the 1860s.
Plague is worldwide in distribution, with most of the human cases reported from developing countries.
Three studies have shown that this bacterium emerged from the gut pathogen Yersinia pseudotuberculosis shortly after the first epidemic. Three biovars (with minor genetic variations) have been identified within the Y pestis clone—Antiqua, Medievalis, and Orientalis. One theory is that these biovars emerged before any of the plague epidemics. In fact, as reported by Drancourt et al (2004), genotyping performed on bacteria derived from the remains of plague victims of the first two epidemics revealed sequences similar to that of Orientalis.
The virulence of this bacterium results from the 32 Y pestis chromosomal genes and two Y pestis –specific plasmids, constituting the only new genetic material acquired since its evolution from its predecessor. These acquired genetic changes have allowed the pathogen to colonize fleas and to use them as vectors for transmission.
Plague is a zoonotic disease that primarily affects rodents; humans are incidental hosts. Dog-to-human transmission was reported in a 2014 outbreak in Colorado. Survival of the bacillus in nature depends on flea-rodent interaction, and human infection does not contribute to the bacteria's persistence in nature. Of the 1500 flea species identified, only 30 of them have been shown to act as vectors of plague. The most prominent of these vectors is Xenopsylla cheopis (oriental rat flea); however, Oropsylla montana has been incriminated as the primary vector for this disease in North America.
Host fatality has been known to be the harbinger of an epidemic. Whether susceptibility and fatality are related is unknown. However, ground squirrels and prairie dogs have been known to be highly susceptible to plague, whereas others have been known to be either moderately susceptible or absolutely resistant to infection.
Plague was first described in the Old Testament and has persisted into the modern era. Plague has caused large-scale epidemics, thereby changing the course of history in many nations. The first pandemic was believed to have started in Africa and killed 100 million people over a span of 60 years. In the Middle Ages, plague killed approximately one fourth of Europe's population. The pandemic that began in China in the 1860s spread to Hong Kong in the 1890s and was subsequently spread by rats transported on ships to Africa, Asia, California, and port cities of South America. In the early twentieth century, plague epidemics accounted for about 10 million deaths in India. As reported in National Geographic, mass graves of plague victims were recently discovered in an area of Venice called "Quarantine Island."
Y pestis is a nonmotile, pleomorphic, gram-negative coccobacillus that is nonsporulating. The bacteria elaborate a lipopolysaccharide endotoxin, coagulase, and a fibrinolysin, which are the principal factors in the pathogenesis of plague. The pathophysiology of plague basically involves two phases—a cycle within the fleas and a cycle within humans.
The key to the organism’s virulence is the phenomenon of "blockage," which aids the transmission of bacteria by fleas. After ingestion of infected blood, the bacteria survive in the midgut of the flea owing to a plasmid-encoded phospholipase D that protects them from digestive juices. The bacteria multiply uninhibited in the midgut to form a mass that extends from the stomach proximally into the esophagus through a sphincterlike structure with sharp teeth called the proventriculus.
It has been shown that this property requires the presence of hemin-producing genes, which are needed for the formation of a biofilm that permits colonization of the proventriculus. In fact, as described by Jarrett et al (2004), this mutation in hemin genes allows colonization in the midgut without extension to the proventriculus. Consequently, the "blockage phenomenon" does not occur, thereby leading to failure of transmission. This blockage causes the flea to die of starvation and dehydration.
As a desperate measure, the flea then repeatedly tries to obtain a meal by biting a host, managing only to regurgitate the infected mass into host's bloodstream. However, the concept that the flea must be engorged before becoming infectious loses support when trying to explain the rapid rate of spread of disease during a plague epidemic. Studies of vectors such as O montana clearly indicate the redundancy of the aforementioned hypothesis, since this vector does not die of blockage and remains infectious for a long period, unlike its counterpart.
Once the flea bites a susceptible host, the bacilli migrate to the regional lymph nodes, are phagocytosed by polymorphonuclear and mononuclear phagocytes, and multiply intracellularly. Survival and replication within macrophages is probably of greatest importance in early stages of the disease. Involved lymph nodes show dense concentrations of plague bacilli, destruction of the normal architecture, and medullary necrosis. With subsequent lysis of the phagocytes, bacteremia can occur and may lead to invasion of distant organs in the absence of specific therapy.
The following are the modes of plague transmission in humans:
- Bites by fleas
- Exposure to humans with pneumonic plague
- Handling of infected carcasses
- Scratches or bites from infected domestic cats
- Exposure to aerosols containing plague-causing bacilli
Another potential cause of plague transmission in humans is contact with an infected dog. In 2014, the Colorado Department of Public Health and Environment (CDPHE) laboratory isolated Y pestis in a blood specimen from a hospitalized man with pneumonia. Further investigation found that the man’s dog had recently died with hemoptysis and that 3 other persons who came into contact with the dog had respiratory symptoms and fever. Specimens from the dog and the other three persons showed evidence of acute Y pestis infection. One of the transmissions may have been human to human, which would be the first such reported US case since 1924.
A few natural plague foci are located in the western United States. From the states of Arizona, California, Colorado, New Mexico, and Utah, 49 cases of plague and 3 attributed deaths were reported from 1994-1999. In 2006, 13 plague cases were reported among residents of New Mexico, Colorado, California, and Texas, two of which resulted in death.
On average, 10-15 cases of human plague are reported annually in the United States. Over time, human cases of plague have moved from crowded cities to the rural West. This has paralleled the observed patterns of introduction of exotic plants and animals. The rate of plague in the United States is low, since most of the endemic areas are rural and largely uninhabited, thereby limiting human exposure. In recent years, and with the potential threat for bioterrorism, the Centers for Disease Control and Prevention (CDC) has specified Y pestis as a Category A bioterrorism agent.
Animal reservoirs in America mostly include squirrels, rabbits, and prairie dogs. However, there has been an established role of domestic cats in the transmission of plague since the late 1970s. Since 1977-1998, 23 cases of human plague associated with cats have been reported from the western states, representing 8% of all reported plague cases during that time. In this scenario, transmission via inhalation was more common than in any other form of plague.
In a study of cat-related plague, mortality was associated with misdiagnosis or delay in treatment. Of the 23 cases from 1977-1998, 5 of 17 bubonic plague cases resulted in death.
In 2014, the Colorado Department of Public Health and Environment (CDPHE) laboratory isolated Y pestis in a blood specimen from a hospitalized man with pneumonia. Further investigation found that the man’s dog had recently died with hemoptysis and that 3 other persons who came into contact with the dog had respiratory symptoms and fever. Specimens from the dog and the other three persons showed evidence of acute Y pestis infection. One of the transmissions may have been human to human, which would be the first such reported US case since 1924.
Most cases of plague reported outside of the United States are from developing countries in Africa and Asia. During 1990-1995, a total of 12,998 cases of plague were reported to the World Health Organization (WHO), particularly from countries such as India, Zaire, Peru, Malawi, and Mozambique. The following countries reported more than 100 cases of plague: China, Congo, India, Madagascar, Mozambique, Myanmar, Peru, Tanzania, Uganda, Vietnam, and Zimbabwe. Several foci are located in the semi-arid regions of northeastern Brazil, and outbreaks have also been reported from Malawi and Zambia. Australia is the only continent that is considered free of plague. The largest enzootic plague area is in North America—the southwestern United States and the Pacific coastal area.
The WHO reports that, in 2003, 9 countries reported a total of 2118 plague cases and 182 deaths, 98.7% and 98.9% of which were reported from Africa, respectively.
The risk of plague-related death depends on the type of plague and whether the infected individual receives appropriate treatment.
The following are the mortality rates associated with the different types of plague:
- Untreated - 100%
- Treated - 50%
- Untreated - 50%-90%
- Treated - 10%-20%
Septicemic plague - 20%-25%
In the United States, most cases of plague occur in whites. Native Americans living in endemic areas of Arizona, New Mexico, and Utah have a 10-fold greater risk of acquiring the disease than non–Native Americans.
Humans are exposed in the domestic or outdoor environment. Infections in the wild are usually isolated or sporadic, causing infections in Indians, hunters, miners, and tourists in the United States and Brazil.
Plague has no sexual predilection.
Most cases of plague occur in persons younger than 20 years.
Achtman M, Zurth K, Morelli G, Torrea G, Guiyoule A, Carniel E. Yersinia pestis, the cause of plague, is a recently emerged clone of Yersinia pseudotuberculosis. Proc Natl Acad Sci U S A. 1999 Nov 23. 96(24):14043-8. [Medline]. [Full Text].
Drancourt M, Roux V, Dang LV, Tran-Hung L, Castex D, Chenal-Francisque V. Genotyping, Orientalis-like Yersinia pestis, and plague pandemics. Emerg Infect Dis. 2004 Sep. 10(9):1585-92. [Medline].
Chain PS, Carniel E, Larimer FW, Lamerdin J, Stoutland PO, Regala WM. Insights into the evolution of Yersinia pestis through whole-genome comparison with Yersinia pseudotuberculosis. Proc Natl Acad Sci U S A. 2004 Sep 21. 101(38):13826-31. [Medline]. [Full Text].
Prentice MB, Rahalison L. Plague. Lancet. 2007 Apr 7. 369(9568):1196-207. [Medline].
Runfola JK, House J, Miller L, Colton L, Hite D, Hawley A, et al. Outbreak of Human Pneumonic Plague with Dog-to-Human and Possible Human-to-Human Transmission - Colorado, June-July 2014. MMWR Morb Mortal Wkly Rep. 2015 May 1. 64(16):429-34. [Medline].
Perry RD, Fetherston JD. Yersinia pestis--etiologic agent of plague. Clin Microbiol Rev. 1997 Jan. 10(1):35-66. [Medline].
Gage K, Lance S, Dennis D, Montenieri J. Human plague in United States: A review of cases from 1988-1992 with comments on likelihood of increased plague activity. Border Epidemiol Bull. 1992. 1:19.
Hinnebusch BJ, Rudolph AE, Cherepanov P, Dixon JE, Schwan TG, Forsberg A. Role of Yersinia murine toxin in survival of Yersinia pestis in the midgut of the flea vector. Science. 2002 Apr 26. 296(5568):733-5. [Medline].
Jarrett CO, Deak E, Isherwood KE, Oyston PC, Fischer ER, Whitney AR, et al. Transmission of Yersinia pestis from an infectious biofilm in the flea vector. J Infect Dis. 2004 Aug 15. 190(4):783-92. [Medline].
Hinnebusch BJ, Perry RD, Schwan TG. Role of the Yersinia pestis hemin storage (hms) locus in the transmission of plague by fleas. Science. 1996 Jul 19. 273(5273):367-70. [Medline].
Eisen RJ, Bearden SW, Wilder AP, Montenieri JA, Antolin MF, Gage KL. Early-phase transmission of Yersinia pestis by unblocked fleas as a mechanism explaining rapidly spreading plague epizootics. Proc Natl Acad Sci U S A. 2006 Oct 17. 103(42):15380-5. [Medline].
Pujol C, Bliska JB. Turning Yersinia pathogenesis outside in: subversion of macrophage function by intracellular yersiniae. Clin Immunol. 2005 Mar. 114(3):216-26. [Medline].
Crook LD, Tempest B. Plague. A clinical review of 27 cases. Arch Intern Med. 1992 Jun. 152(6):1253-6. [Medline].
Centers for Disease Control and Prevention. Plague in the Americas. Centers for Disease Control and Prevention. Available at http://wwwnc.cdc.gov/eid/. Accessed: October 27, 2009.
MMWR. Human plague--United States, 1993-1994. MMWR Morb Mortal Wkly Rep. 1994 Apr 8. 43(13):242-6. [Medline].
Kugeler KJ, Staples JE, Hinckley AF, Gage KL, Mead PS. Epidemiology of human plague in the United States, 1900-2012. Emerg Infect Dis. 2015 Jan. 21 (1):16-22. [Medline].
Gage KL, Dennis DT, Orloski KA, Ettestad P, Brown TL, Reynolds PJ, et al. Cases of cat-associated human plague in the Western US, 1977-1998. Clin Infect Dis. 2000 Jun. 30(6):893-900. [Medline].
Butler T. Yersinia infections: centennial of the discovery of the plague bacillus. Clin Infect Dis. 1994 Oct. 19(4):655-61; quiz 662-3. [Medline].
Marshall JD Jr, Quy DV, Gibson FL. Asymptomatic pharyngeal plague infection in Vietnam. Am J Trop Med Hyg. 1967 Mar. 16(2):175-7. [Medline].
Weniger BG, Warren AJ, Forseth V, Shipps GW, Creelman T, Gorton J. Human bubonic plague transmitted by a domestic cat scratch. JAMA. 1984 Feb 17. 251(7):927-8. [Medline].
Sebbane F, Jarrett CO, Gardner D, Long D, Hinnebusch BJ. Role of the Yersinia pestis plasminogen activator in the incidence of distinct septicemic and bubonic forms of flea-borne plague. Proc Natl Acad Sci U S A. 2006 Apr 4. 103(14):5526-30. [Medline].
Hinnebusch BJ, Jarrett CO, Callison JA, Gardner D, Buchanan SK, Plano GV. Role of the Yersinia pestis Ail protein in preventing a protective polymorphonuclear leukocyte response during bubonic plague. Infect Immun. 2011 Dec. 79(12):4984-9. [Medline]. [Full Text].
[Guideline] Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of america. Clin Infect Dis. 2014 Jul 15. 59(2):e10-52. [Medline].
Chanteau S, Rahalison L, Ralafiarisoa L, Foulon J, Ratsitorahina M, Ratsifasoamanana L. Development and testing of a rapid diagnostic test for bubonic and pneumonic plague. Lancet. 2003 Jan 18. 361(9353):211-6. [Medline].
Hinnebusch J, Schwan TG. New method for plague surveillance using polymerase chain reaction to detect Yersinia pestis in fleas. J Clin Microbiol. 1993 Jun. 31(6):1511-4. [Medline]. [Full Text].
Inglesby TV, Dennis DT, Henderson DA. Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA. 2000 May 3. 283(17):2281-90. [Medline].
Smith MD, Vinh DX, Nguyen TT, Wain J, Thung D, White NJ. In vitro antimicrobial susceptibilities of strains of Yersinia pestis. Antimicrob Agents Chemother. 1995 Sep. 39(9):2153-4. [Medline].
Byrne WR, Welkos SL, Pitt ML, Davis KJ, Brueckner RP, Ezzell JW, et al. Antibiotic treatment of experimental pneumonic plague in mice. Antimicrob Agents Chemother. 1998 Mar. 42(3):675-81. [Medline].
Greenfield RA, Bronze MS. Current therapy and the development of therapeutic options for the treatment of diseases due to bacterial agents of potential biowarfare and bioterrorism. Curr Opin Investig Drugs. 2004 Feb. 5(2):135-40. [Medline].
Rahalison L, Vololonirina E, Ratsitorahina M. Diagnosis of bubonic plague by PCR in Madagascar under field conditions. J Clin Microbiol. 2000 Jan. 38(1):260-3. [Medline].
Greenfield RA, Drevets DA, Machado LJ, Voskuhl GW, Cornea P, Bronze MS. Bacterial pathogens as biological weapons and agents of bioterrorism. Am J Med Sci. 2002 Jun. 323(6):299-315. [Medline].
Cavanaugh DC, Elisberg BL, Llewellyn CH, Marshall JD Jr, Rust JH Jr, Williams JE, et al. Plague immunization. V. Indirect evidence for the efficacy of plague vaccine. J Infect Dis. 1974 May. 129:Suppl:S37-40. [Medline].
Sun W, Roland KL, Curtiss R 3rd. Developing live vaccines against plague. J Infect Dev Ctries. 2011 Sep 14. 5(9):614-27. [Medline].
Casadevall A. Passive antibody administration (immediate immunity) as a specific defense against biological weapons. Emerg Infect Dis. 2002 Aug. 8(8):833-41. [Medline].
Williamson ED, Eley SM, Stagg AJ, Green M, Russell P, Titball RW. A single dose sub-unit vaccine protects against pneumonic plague. Vaccine. 2000 Oct 15. 19(4-5):566-71. [Medline].
Demeure CE, Derbise A, Carniel E. Oral vaccination against plague using Yersinia pseudotuberculosis. Chem Biol Interact. 2016 Apr 1. [Medline].
Li B, Du C, Zhou L, Bi Y, Wang X, Wen L, et al. Humoral and cellular immune responses to Yersinia pestis infection in long-term recovered plague patients. Clin Vaccine Immunol. 2011 Dec 21. [Medline].
Galimand M, Guiyoule A, Gerbaud G, Rasoamanana B, Chanteau S, Carniel E. Multidrug resistance in Yersinia pestis mediated by a transferable plasmid. N Engl J Med. 1997 Sep 4. 337(10):677-80. [Medline].
Alibek K, Handelman S. Biohazard: The Chiling True Story of the Largest Covert Biological Weapons Program in the World - Told from Ihe Inside By The Man Who Ran It. Random House Inc, New York; 1999.
Achtman M, Morelli G, Zhu P, Wirth T, Diehl I, Kusecek B. Microevolution and history of the plague bacillus, Yersinia pestis. Proc Natl Acad Sci U S A. 2004 Dec 21. 101(51):17837-42. [Medline]. [Full Text].
Alsofrom DJ, Mettler FA, Mann JM. Radiographic manifestations of plague in New Mexico, 1975-1980. A review of 42 proved cases. Radiology. 1981 Jun. 139(3):561-5. [Medline].
Ampel NM. Plagues--what's past is present: thoughts on the origin and history of new infectious diseases. Rev Infect Dis. 1991 Jul-Aug. 13(4):658-65. [Medline].
Anderson GP, King KD, Cao LK. Quantifying serum antiplague antibody with a fiber-optic biosensor. Clin Diagn Lab Immunol. 1998 Sep. 5(5):609-12. [Medline].
Ansari BM. An account of bubonic plague in seventeenth century India in an autobiography of a Mughal emperor. J Infect. 1994 Nov. 29(3):351-2. [Medline].
Becker TM, Poland JD, Quan TJ. Plague meningitis--a retrospective analysis of cases reported in the United States, 1970-1979. West J Med. 1987 Nov. 147(5):554-7. [Medline].
Begier EM, Asiki G, Anywaine Z, Yockey B, Schriefer ME, Aleti P, et al. Pneumonic plague cluster, Uganda, 2004. Emerg Infect Dis. 2006 Mar. 12(3):460-7. [Medline].
Bertherat E, Lamine KM, Formenty P. [Major pulmonary plague outbreak in a mining camp in the Democratic Republic of Congo: brutal awakening of an old scourge]. Med Trop (Mars). 2005 Nov. 65(6):511-4. [Medline].
Butler T. Plague and tularemia. Pediatr Clin North Am. 1979 May. 26(2):355-66. [Medline].
Butler T. The black death past and present. 1. Plague in the 1980s. Trans R Soc Trop Med Hyg. 1989 Jul-Aug. 83(4):458-60. [Medline].
Campbell GL, Hughes JM. Plague in India: a new warning from an old nemesis. Ann Intern Med. 1995 Jan 15. 122(2):151-3. [Medline].
Can Dis Wkly Rep. Human plague in 1990. Can Dis Wkly Rep. 1991 Nov 30. 17(48):266, 269-70. [Medline].
Casman EA, Fischhoff B. Risk communication planning for the aftermath of a plague bioattack. Risk Anal. 2008 Oct. 28(5):1327-42. [Medline].
Centers for Disease Control. From the Centers for Disease Control and Prevention. Detection of notifiable diseases through surveillance for imported plague--New York, September-October 1994. JAMA. 1995 Jan 18. 273(3):193. [Medline].
Centers for Disease Control. From the Centers for Disease Control. Pneumonic plague--Arizona, 1992. JAMA. 1992 Oct 28. 268(16):2146-7. [Medline].
Chanteau S, Ratsifasoamanana L, Rasoamanana B. Plague, a reemerging disease in Madagascar. Emerg Infect Dis. 1998 Jan-Mar. 4(1):101-4. [Medline].
Chanteau S, Ratsitorahina M, Rahalison L. Current epidemiology of human plague in Madagascar. Microbes Infect. 2000 Jan. 2(1):25-31. [Medline].
Chen TH, Elberg SS, Eisler DM. Immunity in plague: protection of the vervet (Cercopithecus aethips) against pneumonic plague by the oral administration of live attenuated Yersinia pestis. J Infect Dis. 1977 Feb. 135(2):289-93. [Medline].
Chernin E. Richard Pearson Strong and the Manchurian epidemic of pneumonic plague, 1910-1911. J Hist Med Allied Sci. 1989 Jul. 44(3):296-319. [Medline].
Christie AB. Plague: review of ecology. Ecol Dis. 1982. 1(2-3):111-5. [Medline].
Cleri DJ, Vernaleo JR, Lombardi LJ. Plague pneumonia disease caused by Yersinia pestis. Semin Respir Infect. 1997 Mar. 12(1):12-23. [Medline].
Cohen RJ, Stockard JL. Pneumonic plague in an untreated plague-vaccinated individual. JAMA. 1967 Oct 23. 202(4):365-6. [Medline].
Coleman MP. A plague epidemic in voluntary quarantine. Int J Epidemiol. 1986 Sep. 15(3):379-85. [Medline].
Cook GC. Plague: past and future implications for India. Public Health. 1995 Jan. 109(1):7-11. [Medline].
Coppes JB. Bubonic plague in pregnancy. J Reprod Med. 1980 Aug. 25(2):91-5. [Medline].
Cramer C, Christensen B. Pneumonic plague in a 15-year-old Utah girl. J Emerg Nurs. 1995 Dec. 21(6):491-3. [Medline].
Craven RB, Maupin GO, Beard ML. Reported cases of human plague infections in the United States, 1970- 1991. J Med Entomol. 1993 Jul. 30(4):758-61. [Medline].
Cunha BA. Anthrax, tularemia, plague, ebola or smallpox as agents of bioterrorism: recognition in the emergency room. Clin Microbiol Infect. 2002 Aug. 8(8):489-503. [Medline].
De Backer C. [Measures taken against the plague in Diest in the fifteenth and sixteenth centuries]. Verh K Acad Geneeskd Belg. 1999. 61(2):273-99. [Medline].
Dennis DT, Hughes JM. Multidrug resistance in plague. N Engl J Med. 1997 Sep 4. 337(10):702-4. [Medline].
Deodhar NS, Yemul VL, Banerjee K. Plague that never was: a review of the alleged plague outbreaks in India in 1994. J Public Health Policy. 1998. 19(2):184-99. [Medline].
Doll JM, Zeitz PS, Ettestad P. Cat-transmitted fatal pneumonic plague in a person who traveled from Colorado to Arizona. Am J Trop Med Hyg. 1994 Jul. 51(1):109-14. [Medline].
Eckert EA. The retreat of plague from Central Europe, 1640-1720: a geomedical approach. Bull Hist Med. 2000 Spring. 74(1):1-28. [Medline].
Ehrenkranz NJ. A. Conan Doyle, Sherlock Holmes, and murder by tropical infection. Rev Infect Dis. 1987 Jan-Feb. 9(1):222-5. [Medline].
Ell SR. Immunity as a factor in the epidemiology of medieval plague. Rev Infect Dis. 1984 Nov-Dec. 6(6):866-79. [Medline].
Elvin SJ, Eyles JE, Howard KA, Ravichandran E, Somavarappu S, Alpar HO, et al. Protection against bubonic and pneumonic plague with a single dose microencapsulated sub-unit vaccine. Vaccine. 2006 May 15. 24(20):4433-9. [Medline].
Fritz CL, Dennis DT, Tipple MA. Surveillance for pneumonic plague in the United States during an international emergency: a model for control of imported emerging diseases. Emerg Infect Dis. 1996 Jan-Mar. 2(1):30-6. [Medline].
Goding JR, McCracken JA, Baird DT. The study of ovarian function in the ewe by means of a vascular autotransplantation technique. J Endocrinol. 1967 Sep. 39(1):37-52. [Medline].
Greenberg SJ. The "Dreadful Visitation": public health and public awareness in seventeenth-century London. Bull Med Libr Assoc. 1997 Oct. 85(4):391-401. [Medline].
Gushulak BD, St John R, Jeychandran T. Human plague in India, August-October, 1994. Can Commun Dis Rep. 1994 Oct 30. 20(20):181-3. [Medline].
Henderson RJ. Plague. Trop Dis Bull. 1969 Jul. 66(7):653-9. [Medline].
Henderson RJ. Summary of recent abstracts. VI. Plague. Trop Dis Bull. 1973 Jul. 70(7):601-7. [Medline].
Hinnebusch BJ. Bubonic plague: a molecular genetic case history of the emergence of an infectious disease. J Mol Med. 1997 Sep. 75(9):645-52. [Medline].
Hoffman SL. Plague in the United States: the "black death" is still alive. Ann Emerg Med. 1980 Jun. 9(6):319-22. [Medline].
Houston JB, Carlile DJ. Prediction of hepatic clearance from microsomes, hepatocytes, and liver slices. Drug Metab Rev. 1997 Nov. 29(4):891-922. [Medline].
Hull HF, Montes JM, Mann JM. Septicemic plague in New Mexico. J Infect Dis. 1987 Jan. 155(1):113-8. [Medline].
Human plague--four states, 2006. MMWR Morb Mortal Wkly Rep. 2006 Sep 1. 55(34):940-3. [Medline].
Human plague--United States, 1993-1994. MMWR Morb Mortal Wkly Rep. 1994 Apr 8. 43(13):242-6. [Medline].
Isaacson M, Hallett AF. Serological studies on human plague in Southern Africa. Part I. Plague antibody levels in a population during a quiescent and a subsequent active period in an endemic region. S Afr Med J. 1975 Jul 12. 49(29):1165-8. [Medline].
Isaacson M, Qhobela QM, Davis DH. Serological studies on human plague in Southern Africa. Part II. A bubonic/pneumonic plague epidemic in Lesotho. S Afr Med J. 1976 Jun 5. 50(24):929-32. [Medline].
Jefferson T, Demicheli V, Pratt M. Vaccines for preventing plague. Cochrane Database Syst Rev. 2000. (2):CD000976. [Medline].
John TJ. Emerging & re-emerging bacterial pathogens in India. Indian J Med Res. 1996 Jan. 103:4-18. [Medline].
Jones AM, Mann J, Braziel R. Human plague in New Mexico: report of three autopsied cases. J Forensic Sci. 1979 Jan. 24(1):26-38. [Medline].
Josko D. Yersinia pestis: still a plague in the 21st century. Clin Lab Sci. 2004 Winter. 17(1):25-9. [Medline].
Kaufmann AF, Boyce JM, Martone WJ. From the Center for Disease Control. Trends in human plague in the United States. J Infect Dis. 1980 Apr. 141(4):522-4. [Medline].
Kilonzo BS. Plague epidemiology and control in eastern and southern Africa during the period 1978 to 1997. Cent Afr J Med. 1999 Mar. 45(3):70-6. [Medline].
Kool JL. Risk of person-to-person transmission of pneumonic plague. Clin Infect Dis. 2005 Apr 15. 40(8):1166-72. [Medline].
Koornhof HJ, Smego RA, Nicol M. Yersiniosis. II: The pathogenesis of Yersinia infections. Eur J Clin Microbiol Infect Dis. 1999 Feb. 18(2):87-112. [Medline].
Lyamuya EF, Nyanda P, Mohammedali H. Laboratory studies on Yersinia pestis during the 1991 outbreak of plague in Lushoto, Tanzania. J Trop Med Hyg. 1992 Oct. 95(5):335-8. [Medline].
Madon MB, Hitchcock JC, Davis RM. An overview of plague in the United States and a report of investigations of two human cases in Kern county, California, 1995. J Vector Ecol. 1997 Jun. 22(1):77-82. [Medline].
Mann JM, Martone WJ, Boyce JM. Endemic human plague in New Mexico: risk factors associated with infection. J Infect Dis. 1979 Sep. 140(3):397-401. [Medline].
Mann JM, Schmid GP, Stoesz PA. Peripatetic plague. JAMA. 1982 Jan 1. 247(1):47-8. [Medline].
Mann JM, Shandler L, Cushing AH. Pediatric plague. Pediatrics. 1982 Jun. 69(6):762-7. [Medline].
McClean KL. An outbreak of plague in northwestern province, Zambia. Clin Infect Dis. 1995 Sep. 21(3):650-2. [Medline].
McEvedy C. The bubonic plague. Sci Am. 1988 Feb. 258(2):118-23. [Medline].
Meyer KF, Cavanaugh DC, Bartelloni PJ. Plague immunization. I. Past and present trends. J Infect Dis. 1974 May. 129:Suppl:S13-8. [Medline].
Mittal V, Rana UV, Jain SK. Quick control of bubonic plague outbreak in Uttar Kashi, India. J Commun Dis. 2004 Dec. 36(4):233-9. [Medline].
MMWR. Detection of notifiable diseases through surveillance for imported plague--New York, September-October 1994. Morb Mortal Wkly Rep. 1994 Nov 11. 43(44):805-7. [Medline].
MMWR. Fatal human plague--Arizona and Colorado, 1996. MMWR Morb Mortal Wkly Rep. 1997 Jul 11. 46(27):617-20. [Medline].
MMWR. Imported bubonic plague--District of Columbia. MMWR Morb Mortal Wkly Rep. 1990 Dec 14. 39(49):895, 901. [Medline].
MMWR. Plague--United States, 1992. MMWR Morb Mortal Wkly Rep. 1992 Oct 23. 41(42):787-90. [Medline].
MMWR. Pneumonic plague--Arizona, 1992. MMWR Morb Mortal Wkly Rep. 1992 Oct 9. 41(40):737-9. [Medline].
MMWR. Prevention of plague: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 1996 Dec 13. 45(RR-14):1-15. [Medline].
Moreno AJ, Reeves TA, Rodriguez AA. Imaging in plague. Eur J Nucl Med. 1987. 13(6):315-7. [Medline].
Morris JT, McAllister CK. Bubonic plague. South Med J. 1992 Mar. 85(3):326-7. [Medline].
Mudur G. India's pneumonic plague outbreak continues to baffle. BMJ. 1995 Sep 16. 311(7007):706. [Medline].
Mwengee W, Butler T, Mgema S. Treatment of plague with gentamicin or doxycycline in a randomized clinical trial in Tanzania. Clin Infect Dis. 2006 Mar 1. 42(5):614-21. [Medline].
Oeding P. [The black death in Norway]. Tidsskr Nor Laegeforen. 1990 Jun 30. 110(17):2204-8. [Medline].
Parmenter RR, Yadav EP, Parmenter CA. Incidence of plague associated with increased winter-spring precipitation in New Mexico. Am J Trop Med Hyg. 1999 Nov. 61(5):814-21. [Medline].
Poos LR. Plague mortality and demographic depression in later medieval England. Yale J Biol Med. 1981 May-Jun. 54(3):227-34. [Medline].
Ratsitorahina M, Chanteau S, Rahalison L. Epidemiological and diagnostic aspects of the outbreak of pneumonic plague in Madagascar. Lancet. 2000 Jan 8. 355(9198):111-3. [Medline].
Ratsitorahina M, Rabarijaona L, Chanteau S. Seroepidemiology of human plague in the Madagascar highlands. Trop Med Int Health. 2000 Feb. 5(2):94-8. [Medline].
Reed WP, Palmer DL, Williams RC. Bubonic plague in the Southwestern United States. A review of recent experience. Medicine (Baltimore). 1970 Nov. 49(6):465-86. [Medline].
Reeder MM, Palmer PE. Acute tropical pneumonias. Semin Roentgenol. 1980 Jan. 15(1):35-49. [Medline].
Risse GB. "A long pull, a strong pull, and all together": San Francisco and bubonic plague, 1907-1908. Bull Hist Med. 1992 Summer. 66(2):260-86. [Medline].
Ruiz A. Plague in the Americas. Emerg Infect Dis. 2001. 7(3 Suppl):539-40. [Medline].
Russell P, Eley SM, Green M. Efficacy of doxycycline and ciprofloxacin against experimental Yersinia pestis infection. J Antimicrob Chemother. 1998 Feb. 41(2):301-5. [Medline].
Russell P, Nelson M, Whittington D. Laboratory diagnosis of plague. Br J Biomed Sci. 1997 Dec. 54(4):231-6. [Medline].
Shangula K. Successful plague control in Namibia. S Afr Med J. 1998 Nov. 88(11):1428-30. [Medline].
Shivaji S, Bhanu NV, Aggarwal RK. Identification of Yersinia pestis as the causative organism of plague in India as determined by 16S rDNA sequencing and RAPD-based genomic fingerprinting. FEMS Microbiol Lett. 2000 Aug 15. 189(2):247-52. [Medline].
Sloan AW. The Black Death in England. S Afr Med J. 1981 Apr 25. 59(18):646-50. [Medline].
Smego RA, Frean J, Koornhof HJ. Yersiniosis I: microbiological and clinicoepidemiological aspects of plague and non-plague Yersinia infections. Eur J Clin Microbiol Infect Dis. 1999 Jan. 18(1):1-15. [Medline].
Solomon T. Alexandre Yersin and the plague bacillus. J Trop Med Hyg. 1995 Jun. 98(3):209-12. [Medline].
Suntsov VV, Huong LT, Suntsova NI. Plague foci in Viet Nam: zoological and parasitological aspects. Bull World Health Organ. 1997. 75(2):117-23. [Medline].
Titball RW, Leary SE. Plague. Br Med Bull. 1998. 54(3):625-33. [Medline].
Tomich PQ, Barnes AM, Devick WS. Evidence for the extinction of plague in Hawaii. Am J Epidemiol. 1984 Feb. 119(2):261-73. [Medline].
Trong P, Nhu TQ, Marshall JD. A mixed pneumonic bubonic plague outbreak in Vietnam. Mil Med. 1967 Feb. 132(2):93-7. [Medline].
Velimirovic B. Plague and Glasnost. First information about human cases in the USSR in 1989 and 1990. Infection. 1990 Nov-Dec. 18(6):388-93. [Medline].
Velimirovic B. Plague in South-East Asia. A brief historical summary and present geographical distribution. Trans R Soc Trop Med Hyg. 1972. 66(3):479-504. [Medline].
Viseltear AJ. The pneumonic plague epidemic of 1924 in Los Angeles. Yale J Biol Med. 1974 Mar. 47(1):40-54. [Medline].
von Reyn CF, Barnes AM, Weber NS. Bubonic plague from exposure to a rabbit: a documented case, and a review of rabbit-associated plague cases in the United States. Am J Epidemiol. 1976 Jul. 104(1):81-7. [Medline].
von Reyn CF, Weber NS, Tempest B. Epidemiologic and clinical features of an outbreak of bubonic plague in New Mexico. J Infect Dis. 1977 Oct. 136(4):489-94. [Medline].
Washington RL, Barkin RM, Hillman JR. Septicemic plague that mimics Reye's syndrome. Am J Dis Child. 1979 Apr. 133(4):434-5. [Medline].
Welty TK. Plague. Am Fam Physician. 1986 Jun. 33(6):159-64. [Medline].
White ME, Gordon D, Poland JD. Recommendations for the control of Yersinia pestis infections. Recommendations from the CDC. Infect Control. 1980 Sep-Oct. 1(5):324-9. [Medline].
Williamson ED, Vesey PM, Gillhespy KJ, Eley SM, Green M, Titball RW. An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model. Clin Exp Immunol. 1999 Apr. 116(1):107-14. [Medline].
Wilson ME. The power of plague. Epidemiology. 1995 Jul. 6(4):458-60. [Medline].
Wilson WR. Antimicrobial chemoprophylaxis. Med Clin North Am. 1983 Jan. 67(1):99-112. [Medline].
Wkly Epidemiol Rec. Epidemic of plague. Wkly Epidemiol Rec. 1992 Oct 16. 67(42):315-6. [Medline].
Wkly Epidemiol Rec. Human plague in 1996. Wkly Epidemiol Rec. 1998 Nov 20. 73(47):366-9. [Medline].
Wkly Epidemiol Rec. Human plague in 1997. Wkly Epidemiol Rec. 1999 Oct 15. 74(41):340-4. [Medline].
Wkly Epidemiol Rec. Plague. Wkly Epidemiol Rec. 1990 Mar 16. 65(11):83-4. [Medline].
Wray R, Jupka K. What does the public want to know in the event of a terrorist attack using plague?. Biosecur Bioterror. 2004. 2(3):208-15. [Medline].
Yom SS. Plague and AIDS in literature. JAMA. 1997 Feb 5. 277(5):437-8. [Medline].
Yule WL. A Scottish doctor's association with the discovery of the plague bacillus. Scott Med J. 1995 Dec. 40(6):184-6. [Medline].